S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
New York lawmakers pass $237 billion budget with policies to jump-start housing market
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
New York lawmakers pass $237 billion budget with policies to jump-start housing market
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
New York lawmakers pass $237 billion budget with policies to jump-start housing market
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
New York lawmakers pass $237 billion budget with policies to jump-start housing market
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis

Cardiol Therapeutics (CRDL) Short Interest Ratio & Short Volume

$1.77
+0.10 (+5.99%)
(As of 04/19/2024 ET)

Cardiol Therapeutics Short Interest Data

Current Short Volume
326,600 shares
Previous Short Volume
273,000 shares
Change Vs. Previous Month
+19.63%
Dollar Volume Sold Short
$591,146.00
Short Interest Ratio / Days to Cover
0.8
Last Record Date
March 31, 2024
Outstanding Shares
68,280,000 shares
Float Size
62,090,000 shares
Short Percent of Float
0.53%
Today's Trading Volume
567,455 shares
Average Trading Volume
275,051 shares
Today's Volume Vs. Average
206%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Cardiol Therapeutics ?

Sign up to receive the latest short interest report for Cardiol Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CRDL Short Interest Over Time

CRDL Days to Cover Over Time

CRDL Percentage of Float Shorted Over Time

Cardiol Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/2024326,600 shares $591,146.00 +19.6%0.5%0.8 $1.81
3/15/2024273,000 shares $414,960.00 -24.4%0.4%0.8 $1.52
2/29/2024361,100 shares $743,866.00 +108.1%0.6%1.1 $2.06
2/15/2024173,500 shares $256,780.00 +16.6%0.3%0.6 $1.48
1/31/2024148,800 shares $181,536.00 +24.4%0.2%0.9 $1.22
1/15/2024119,600 shares $124,384.00 -9.1%0.2%0.8 $1.04
12/31/2023131,500 shares $110,880.80 -31.4%0.2%0.7 $0.84
12/15/2023191,800 shares $165,926.18 -14.7%0.3%0.9 $0.87
11/30/2023224,800 shares $206,029.20 -11.9%0.4%1 $0.92
11/15/2023255,200 shares $214,368.00 -17.5%0.4%1.2 $0.84
10/31/2023309,500 shares $256,885.00 -4.8%0.5%1.4 $0.83
10/15/2023325,100 shares $266,582.00 +32.1%0.5%1.2 $0.82
9/30/2023246,100 shares $220,259.50 +132.0%0.4%1.2 $0.90
9/15/2023106,100 shares $103,447.50 +46.6%0.2%0.6 $0.98
8/31/202372,400 shares $79,640.00 -49.2%0.1%0.4 $1.10
8/15/2023142,400 shares $134,482.56 +8.5%0.2%0.8 $0.94
7/31/2023131,200 shares $141,696.00 +49.3%0.2%0.7 $1.08
7/15/202387,900 shares $71,541.81 +3.8%0.1%0.7 $0.81
6/30/202384,700 shares $75,383.00 -26.7%0.1%0.6 $0.89
6/15/2023115,500 shares $91,533.75 -23.8%0.2%0.8 $0.79
5/31/2023151,500 shares $102,126.15 +1.3%0.3%1.3 $0.67
5/15/2023149,600 shares $82,280.00 +18.8%0.2%1.5 $0.55
4/30/2023125,900 shares $78,007.64 -21.1%0.2%1.1 $0.62
4/15/2023159,500 shares $82,541.25 -12.9%0.3%1.5 $0.52
3/31/2023183,100 shares $89,224.63 +8.9%0.3%1.8 $0.49
3/15/2023168,100 shares $82,369.00 +8.3%0.3%1.7 $0.49
2/28/2023155,200 shares $82,318.08 -41.3%0.3%1.3 $0.53
2/15/2023264,500 shares $150,765.00 -10.0%0.5%2.2 $0.57
1/31/2023293,800 shares $206,923.34 +8.9%0.5%2.3 $0.70
1/15/2023269,800 shares $217,350.88 +6.7%0.5%1.9 $0.81
12/30/2022252,900 shares $128,979.00 +11.0%0.4%1.5 $0.51
12/15/2022227,800 shares $152,626.00 -3.1%0.4%1.1 $0.67
11/30/2022235,100 shares $121,147.03 +10.3%0.4%1 $0.52
11/15/2022213,100 shares $135,169.33 -10.8%0.4%0.8 $0.63
10/31/2022239,000 shares $143,113.20 -33.0%0.4%0.9 $0.60
10/15/2022356,900 shares $232,698.80 -29.6%0.6%1.4 $0.65
9/30/2022506,600 shares $521,798.00 +2.2%0.9%2.2 $1.03
9/15/2022495,800 shares $609,834.00 +3.1%0.9%2.6 $1.23
8/31/2022481,100 shares $538,832.00 +22.4%0.8%3.1 $1.12
8/15/2022393,200 shares $499,364.00 +9.2%0.7%2.8 $1.27
Global crypto currency reset (41 major banks signed up) (Ad)

Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...

 Here's everything you need to know.

CRDL Short Interest - Frequently Asked Questions

What is Cardiol Therapeutics' current short interest?

Short interest is the volume of Cardiol Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 326,600 shares of CRDL short. 0.53% of Cardiol Therapeutics' shares are currently sold short. Learn More on Cardiol Therapeutics' current short interest.

What is a good short interest ratio for Cardiol Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRDL shares currently have a short interest ratio of 1.0. Learn More on Cardiol Therapeutics's short interest ratio.

Which institutional investors are shorting Cardiol Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cardiol Therapeutics: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Cardiol Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.53% of Cardiol Therapeutics' floating shares are currently sold short.

Is Cardiol Therapeutics' short interest increasing or decreasing?

Cardiol Therapeutics saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 326,600 shares, an increase of 19.6% from the previous total of 273,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Cardiol Therapeutics' float size?

Cardiol Therapeutics currently has issued a total of 68,280,000 shares. Some of Cardiol Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cardiol Therapeutics currently has a public float of 62,090,000 shares.

How does Cardiol Therapeutics' short interest compare to its competitors?

0.53% of Cardiol Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Cardiol Therapeutics: Outlook Therapeutics, Inc. (6.16%), Vigil Neuroscience, Inc. (7.06%), aTyr Pharma, Inc. (0.64%), bluebird bio, Inc. (27.21%), BioAtla, Inc. (11.62%), Zura Bio Limited (3.32%), Agenus Inc. (227.78%), Omega Therapeutics, Inc. (19.78%), DBV Technologies S.A. (0.28%), Sangamo Therapeutics, Inc. (6.38%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Cardiol Therapeutics stock?

Short selling CRDL is an investing strategy that aims to generate trading profit from Cardiol Therapeutics as its price is falling. CRDL shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Cardiol Therapeutics?

A short squeeze for Cardiol Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CRDL, which in turn drives the price of the stock up even further.

How often is Cardiol Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRDL, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:CRDL) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners